RS4148325 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cance..."
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Plasma bilirubin (Z,Z) levels in chronic kidney disease | T | OR: 0.43 | 2E-227 | PubMed |
| Plasma bilirubin (E,E)* levels in chronic kidney disease | T | OR: 0.45 | 5E-204 | PubMed |
| Metabolite peak levels (QI14931) | T | OR: 0.6 | 2E-93 | PubMed |
| Bilirubin levels in extreme obesity | — | — | 5E-93 | PubMed |
| Metabolite peak levels (QI1087) | T | OR: 0.54 | 3E-75 | PubMed |
| Metabolite peak levels (QI14010) | T | OR: 0.53 | 2E-72 | PubMed |
| Metabolite peak levels (QI14055) | T | OR: 0.5 | 1E-64 | PubMed |
| Bilirubin levels | — | OR: 0.17 | 5E-62 | PubMed |
| Metabolite peak levels (QI1481) | T | OR: 0.47 | 6E-57 | PubMed |
| Metabolite peak levels (QI11242) | T | OR: 0.45 | 1E-53 | PubMed |
| Metabolite peak levels (QI1379) | T | OR: 0.45 | 3E-47 | PubMed |
| Metabolite peak levels (QI1483) | T | OR: 0.42 | 1E-45 | PubMed |
| Metabolite peak levels (QI4952) | T | OR: 0.4 | 4E-42 | PubMed |
| Bilirubin levels in sarilumab-treated rheumatoid arthritis patients | T | OR: 0.28 | 3E-41 | PubMed |
| Cholelithiasis and cholecystitis (PheCode 574) | C | OR: 0.13 | 6E-41 | PubMed |
| Xanthurenate levels | T | OR: 0.15 | 2E-37 | PubMed |
| Cholelithiasis (PheCode 574.1) | C | OR: 0.14 | 5E-36 | PubMed |
| Total bilirubin levels in HIV-1 infection | — | OR: 0.11 | 1E-30 | PubMed |
| Metabolite peak levels (QI15805) | T | OR: 0.3 | 6E-25 | PubMed |
| Xanthurenate levels | T | OR: 0.17 | 2E-23 | PubMed |